Featured Research

from universities, journals, and other organizations

University of Kentucky Researcher Discovers Drug That Shows Promise In Treating Rare Cancer

Date:
October 4, 2000
Source:
University Of Kentucky Medical Center
Summary:
New research published recently in the journal Thyroid shows that paclitaxel (Taxol®) has significant clinical activity against anaplastic thyroid carcinoma (ATC).

New research published recently in the journal Thyroid shows that paclitaxel (Taxol®) has significant clinical activity against anaplastic thyroid carcinoma (ATC). The research study was led by Kenneth B. Ain, M.D., associate professor, Division of Endocrinology, Department of Internal Medicine, University of Kentucky College of Medicine, and Medical Service at the Veterans Affairs Medical Center in Lexington.

Related Articles


This study is an example of how treatments can be developed from basic research through clinical trials in patients entirely by faculty at the UK Chandler Medical Center and the VAMC in Lexington.

Paclitaxel is a compound that was isolated from the bark of the Pacific yew tree. The U.S. Food and Drug Administration has approved paclitaxel to treat breast and ovarian cancer, non-small-cell lung cancer, and AIDS-related Kaposi's sarcoma.

ATC is a rare disease with no effective therapies. It is the most aggressive solid cancer and is always fatal, with a mean survival time after diagnosis of two to five months with treatment. ATC accounts for 1.6 percent of all thyroid cancers, and there are about 300 cases in the United States each year.

Ain created the thyroid cancer program at the UK Chandler Medical Center. Patients from around the world receive clinical care through the program.

The recently published study was a Phase II trial, or a clinical trial required for approval of a drug indication by the Food and Drug Administration that focuses on the effectiveness of a single drug. In the study, paclitaxel was infused continuously over 96 hours every three weeks for one to six treatments. Of the 19 evaluable patients, 53 percent showed a response to the drug, meaning their survival time increased. However, treatment with paclitaxel did not alter the mortality rate.

Ain's team currently is researching adding other drugs to paclitaxel in an effort to find more effective treatments for ATC.


Story Source:

The above story is based on materials provided by University Of Kentucky Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Kentucky Medical Center. "University of Kentucky Researcher Discovers Drug That Shows Promise In Treating Rare Cancer." ScienceDaily. ScienceDaily, 4 October 2000. <www.sciencedaily.com/releases/2000/09/000913205318.htm>.
University Of Kentucky Medical Center. (2000, October 4). University of Kentucky Researcher Discovers Drug That Shows Promise In Treating Rare Cancer. ScienceDaily. Retrieved December 18, 2014 from www.sciencedaily.com/releases/2000/09/000913205318.htm
University Of Kentucky Medical Center. "University of Kentucky Researcher Discovers Drug That Shows Promise In Treating Rare Cancer." ScienceDaily. www.sciencedaily.com/releases/2000/09/000913205318.htm (accessed December 18, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, December 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Kids Die While Under Protective Services

Kids Die While Under Protective Services

AP (Dec. 18, 2014) — As part of a six-month investigation of child maltreatment deaths, the AP found that hundreds of deaths from horrific abuse and neglect could have been prevented. AP's Haven Daley reports. (Dec. 18) Video provided by AP
Powered by NewsLook.com
UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) — Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com
When You Lose Weight, This Is Where The Fat Goes

When You Lose Weight, This Is Where The Fat Goes

Newsy (Dec. 17, 2014) — Can fat disappear into thin air? New research finds that during weight loss, over 80 percent of a person's fat molecules escape through the lungs. Video provided by Newsy
Powered by NewsLook.com
Why Your Boss Should Let You Sleep In

Why Your Boss Should Let You Sleep In

Newsy (Dec. 17, 2014) — According to research out of the University of Pennsylvania, waking up for work is the biggest factor that causes Americans to lose sleep. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins